「JCN Newswire」記事一覧
-
Xunce (3317.HK) Released Profit Alert: Revenue Doubles, Surpasses Expectations by a Wide Margin, China's Palantir Rises!
-
Hong Kong Tech Innovators Drive Success at Mobile World Congress and 4YFN Barcelona 2026
-
Philippine Hotel Innovation Summit 2026 Concludes in Manila, Setting a New Blueprint for the Future of Hospitality
-
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
-
富士通Japan、大分市民図書館において「デジタル認証アプリ」を活用したWeb利用者登録サービスを構築し、運用を開始
-
Honda、米国生産乗用車の日本導入を決定
-
Core Concepts Physiotherapy Partners with Podiatry Quest to Deliver Enhanced Assessments for Patients with Plantar Fasciitis
-
FinHarbor Completes Core Deployment of Hybrid Neobank Platform for Asterium in Uzbekistan
-
Base58 Labs、3,500万ドルのPre-Series A資金調達を受け「BASIS」プラットフォーム開発を加速、独自の「BHLE」インフラを統合
-
Hong Kong International Jewellery Show opens today showcasing global designs and trends
-
BASIS Accelerates Platform Development Following $35M Capital Injection
-
Lincotrade Unveils Freehold Residential Project, The Shang Residence, in Kuala Lumpur, Malaysia
-
Exito Media Concepts Announces the 32nd Edition of the Manufacturing IT Summit - Thailand 2026
-
The Tomorrow Company Launches With a Bold Mandate to Build the Infrastructure Layer of the AI-Native Financial Era.
-
The HK International Diamond, Gem & Pearl Show opens today; The HK International Jewellery Show starts Wednesday
-
三菱重工とソフトバンク、AI-RANのエッジデータセンター化に向け協業
-
AI Safety Asia Advances Crisis Diplomacy and Evidence-Based AI Governance at India AI Impact Summit 2026
-
Quam Plus Financial Group and Dinosaur Financial Group Announce Strategic Partnership to Expand Cross-Border Capital Markets Access
-
エーザイとMerck & Co.,Inc.、「レンビマ(R)」（レンバチニブ）と「ウェリレグ(R)」（ベルズチファン）の併用療法が治療歴のある進行腎細胞がんにおいて、カボザンチニブと比較して、疾患進行または死亡のリスクを30％低減
-
CALB (3931.HK) Announced a Positive Profit Alert
-
三菱重工コンプレッサ、スイスの回転機器メンテナンス工事会社AST Turbo AGを買収
-
Honda、2026年1月度 四輪車 生産・販売・輸出実績を発表
-
トヨタ、2026年1月 販売・生産・輸出実績を発表
-
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
-
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
-
HKTDC welcomes the 2026-27 Budget
-
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
-
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
-
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
-
エクステル「日本企業エグゼクティブ・チーム」ランキングを発表
